NCT07743788Completed
Efficacy, Satisfaction, and Safety of the Mesolipo® Protocol for the Treatment of Localized Adiposity
Eficácia,Satisfação e Segurança do Protocolo Mesolipo® no Tratamento da Gordura Localizada: um Estudo Randomizado
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
This randomized, split-body clinical trial aims to evaluate the efficacy, safety, and participant satisfaction of the Mesolipo® protocol for the treatment of localized adiposity. Participants will receive the Mesolipo® intervention on one side of the body and an active comparator on the contralateral side. Outcomes will be assessed through standardized clinical, photographic, ultrasonographic, and patient-reported measures over a 90-day follow-up period to determine treatment effectiveness and safety.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 17 Jul 2026
- Start date
- 1 Jan 2025
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Antony de Paula Barbosa
- NCT number
- NCT07743788
What you commit to
- Study type: Interventional
- Participants enrolled: 12
- From 1 Jan 2025 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous aesthetic treatment in the target area within the period defined by the protocol.
- Participation in another clinical trial within the previous 30 days.
Other illness
- Active infection or inflammatory skin disease at the treatment site.
- Severe systemic disease or any condition that, in the investigator's opinion, could interfere with study participation or outcome assessment.
Lab values
- Known hypersensitivity to sodium deoxycholate or any study product component.
Other
- Pregnancy or breastfeeding.
- Inability or unwillingness to comply with study procedures.
Who the study is looking for
- Adults aged 18 years or older.
- Presence of localized adiposity suitable for treatment with the Mesolipo® protocol.
- Willingness and ability to provide written informed consent.
- Ability to comply with all study procedures and follow-up visits.
- Stable body weight for at least 3 months before enrollment.
- Agreement to maintain usual diet and physical activity habits throughout the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Antony Barbosa Coordinator of this site? Confirm its status | Belo Horizonte | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.